All In Biotech

Drug Trial Radar · NCT04924296

A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis

A Multicentre, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Study to Evaluate the Efficacy and Safety of fSHR-1314 in Adult Patients With Lupus Nephritis

Last checked: Nov 19, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Jun 28, 2021

Primary completion

Dec 25, 2021

Study completion Sep 3, 2022

Sponsor

Sponsor type
Industry
First posted
Jun 11, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate the efficacy of SHR-1314 at Week 12 in subjects with proliferation lupus nephritis in terms of improvement of 24h UPCR, compared to placebo. The study will also assess the safety and tolerability of SHR-1314 in the patient population over the study period.

Conditions

  • Lupus Nephritis

Interventions

  • SHR-1314Drug

    SHR-1314 s.c. + Steroids

  • PlaceboDrug

    Placebo s.c. + Steroids

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. percentage change of 24 hours UPCR from baseline to Week 12.Time frame: at 12 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.